文献速递认知障碍与痴呆

中年期神经营养因子与15年后无痴呆成人β-淀粉样蛋白和tau负荷体内测量的关联

Association of Neurotrophic Factors at Midlife With In Vivo Measures of β-Amyloid and Tau Burden 15 Years Later in Dementia-Free Adults.
PubMed 文献 · Neurology · 2024-03-12

该研究基于Framingham心脏研究队列,纳入414名认知健康成人(平均年龄41±9岁,51%女性),分析中年期血清BDNF和VEGF水平与约15年后11C-PiB淀粉样蛋白和18F-Flortaucipir tau-PET影像的关联。结果显示BDNF和VEGF与鼻区tau信号呈负相关,高BDNF和高VEGF水平与较低的鼻区和下颞叶tau相关,BDNF-鼻区tau关联仅见于男性,高VEGF与绝经后女性较低淀粉样蛋白负荷相关。

要点

  • 中年期血清BDNF和VEGF水平与约15年后鼻区tau信号呈负相关。
  • 高BDNF(≥32,450 pg/mL)和高VEGF(≥488 pg/mL)水平与较低的鼻区和下颞叶tau相关。
  • BDNF-鼻区tau关联仅见于男性;高VEGF与绝经后女性较低淀粉样蛋白负荷相关。

核心结论

  • 中年期血清BDNF和VEGF水平与近20年后的体内tau测量呈稳健关联,提示神经营养因子可能作为AD风险预测的有价值血液生物标志物。

研究设计与样本

  • 横断面分析,使用Framingham心脏研究(FHS)社区队列中认知健康的后代队列和第三代队列参与者数据。
  • BDNF和VEGF分别在第三代队列第2检查周期(2005-2008)和第1检查周期(2002-2005)测量,后代队列在第7检查周期(1998-2001)测量。
  • 参与者于2015-2021年接受11C-匹兹堡化合物B淀粉样蛋白PET和18F-Flortaucipir tau-PET成像。
  • 样本共414人,平均年龄41±9岁,51%女性。

主要发现

  • 连续BDNF与鼻区tau信号相关(β=-0.15±0.06,p=0.018),连续VEGF与鼻区tau信号相关(β=-0.19±0.09,p=0.043)。
  • 高BDNF(≥32,450 pg/mL)与较低鼻区tau相关(β=-0.27±0.11,p=0.016),高VEGF(≥488 pg/mL)与较低鼻区tau相关(β=-0.40±0.14,p=0.004)。
  • 高BDNF与较低下颞叶tau相关(β=-0.24±0.11,p=0.028),高VEGF与较低下颞叶tau相关(β=-0.26±0.13,p=0.049)。
  • BDNF-鼻区tau关联仅见于男性。
  • 高VEGF与绝经后女性较低淀粉样蛋白负荷相关(β=-1.96±0.70,p=0.013,每1 pg/mL)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Neurotrophic factors (NTFs) play an important role in Alzheimer disease (AD) pathophysiology. Brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) are important NTFs. However, a direct link of BDNF and VEGF circulating levels with in vivo measures of amyloid-β (Aβ) and tau burden remains to be elucidated. We explored the relationship of BDNF and VEGF serum levels with future brain Aβ and tau pathology in a cohort of cognitively healthy, predominantly middle-aged adults and tested for possible effect modifications by sex and menopausal status. METHODS: This cross-sectional analysis was conducted using data from the Framingham Heart Study (FHS), a community-based cohort study. The study sample included cognitively healthy participants from the FHS Offspring and Third-generation cohorts. BDNF and VEGF were measured in the third-generation cohort during examination cycles 2 (2005-2008) and 1 (2002-2005), respectively, and in the offspring cohort during examination cycle 7 (1998-2001). Participants underwent 11C-Pittsburgh compound B amyloid and 18F-Flortaucipir tau-PET imaging (2015-2021). Linear regression models were used to assess the relationship of serum BDNF and VEGF levels with regional tau and global Aβ, adjusting for potential confounders. Interactions with sex and menopausal status were additionally tested. RESULTS: The sample included 414 individuals (mean age = 41 ± 9 years; 51% female). Continuous measures of BDNF and VEGF were associated with tau signal in the rhinal region after adjustment for potential confounders (β = -0.15 ± 0.06, p = 0.018 and β = -0.19 ± 0.09, p = 0.043, respectively). High BDNF (≥32,450 pg/mL) and VEGF (≥488 pg/mL) levels were significantly related to lower rhinal tau (β = -0.27 ± 0.11, p = 0.016 and β = -0.40 ± 0.14, p = 0.004, respectively) and inferior temporal tau (β = -0.24 ± 0.11, p = 0.028 and β = -0.26 ± 0.13, p = 0.049, respectively). The BDNF-rhinal tau association was observed only among male individuals. Overall, BDNF and VEGF were not associated with global amyloid; however, high VEGF levels were associated with lower amyloid burden in postmenopausal women (β = -1.96 ± 0.70, p = 0.013, per 1 pg/mL). DISCUSSION: This study demonstrates a robust association between BDNF and VEGF serum levels with in vivo measures of tau almost 2 decades later. These findings add to mounting evidence from preclinical studies suggesting a role of NTFs as valuable blood biomarkers for AD risk prediction.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Weinstein G, Kojis DJ, Ghosh S, et al. Association of Neurotrophic Factors at Midlife With In Vivo Measures of β-Amyloid and Tau Burden 15 Years Later in Dementia-Free Adults. Neurology. 2024. PMID: 38471064. doi:10.1212/WNL.0000000000209198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。